Department of Clinical Biochemistry, Gentofte University Hospital, University of Copenhagen, Hellerup, Denmark. stst@geh.regionh.dk

Abstract

AIM:

To compare the safety and efficacy of once-daily pitavastatin (1, 2, and 4 mg) and pravastatin (10, 20, and 40 mg) in elderly patients (≥ 65 years of age) with primary hypercholesterolaemia or combined (mixed) dyslipidaemia.